- Research works
- 20 ▲ 103% vs 2013–17
- Citations
- 520 25.7 per fractional work
- Top-10% rate
- 22.5% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Bayer (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 3.8×. Every wedge is a field page.
- Decision Sciences 3.8×
- Pharmacology, Toxicology and Pharmaceutics 3.4×
- Medicine 2.9×
- Mathematics 2.5×
- Materials Science 1.5×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Physics and Astronomy 1.0×
- Psychology 0.9×
- Engineering 0.8×
- Neuroscience 0.8×
- Immunology and Microbiology 0.5×
- Computer Science 0.5×
- Economics, Econometrics and Finance 0.4×
- Health Professions 0.3×
- Social Sciences 0.1×
Which keywords describe research at Bayer (Finland)?
By fractional works in all years, weighted toward what it does more of than the world: Family Planning, Reproductive Health, Contraception, Unintended Pregnancy, Cardiovascular Disease, Breast Cancer, Maternal Mortality and Tissue Engineering.
- Maternal Mortality
- Epidemiology
- Unintended Pregnancy
- Reproductive Health
- Family Planning
- Contraception
- Cardiovascular Disease
- Breast Cancer
- Tissue Engineering
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Family Planning2▲ 183×2 topics
- Reproductive Health2▲ 219×2 topics
- Contraception2▲ 359×1 topic
- Unintended Pregnancy2▲ 359×1 topic
- Cardiovascular Disease2▲ 7.0×11 topics
- Epidemiology2▲ 1.90×6 topics
- Breast Cancer1▲ 21×4 topics
- Maternal Mortality1▲ 29×2 topics
- Tissue Engineering1▲ 9.4×5 topics
Which research topics does Bayer (Finland) publish most on?
By volume in 2022–2025: Reproductive Health and Contraception, Risk and Safety Analysis, Estrogen and related hormone effects and 3D Printing in Biomedical Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 1 works
- 2 Risk and Safety Analysis Statistics, Probability and Uncertainty 0 works
- 3 Estrogen and related hormone effects Genetics 0 works
- 4 3D Printing in Biomedical Research Biomedical Engineering 0 works
- 5 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 0 works
- 6 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
- 7 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 0 works
- 8 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
- 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 10 Sleep and related disorders Experimental and Cognitive Psychology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bayer (Finland)'s research output changed?
Output in 2018–2022 was 103% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Espoo
- Aalto University
- VTT Technical Research Centre of Finland
- Nokia (Finland)
- Helsinki Institute for Information Technology
- Geological Survey of Finland
- Orion Corporation (Finland)
- Microsoft (Finland)
- Neste Oil (Finland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.